2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine | CAS:23449-08-3

We serve 2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine CAS:23449-08-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine

Chemical Name:2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine
CAS.NO:23449-08-3
Synonyms:2-(4-Bromphenyl)-4,6-diphenyl-symm.-triazin
2-(4-bromo-phenyl)-4,6-diphenyl-[1,3,5]triazine
Molecular Formula:C21H14BrN3
Molecular Weight:388.26000
 
Physical and Chemical Properties:
Density:
Melting point:ºC
Boiling point:ºC
Flash point:ºC
Index of Refraction:
 
Specification:
Appearance:White to off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-bromo-phenyl)-4,6-diphenyl-[1,3,5]triazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine Use and application,2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine technical grade,usp/ep/jp grade.


Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold.4-Methyl-benzylidene camphor manufacturer The mode of cooperation between domestic API companies and large international companies can lower the export threshold.Bromotri(1-Pyrrolidinyl)Phosphonium Hexafluorophosphate supplier This followed a declaration Thursday by the World Health Organization that the coronavirus outbreak is a Public Health Emergency of International Concern.6-Bromonicotinic acid vendor This followed a declaration Thursday by the World Health Organization that the coronavirus outbreak is a Public Health Emergency of International Concern.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”